BIG PHARMA WATCH: AARP REPORT SHINES LIGHT ON SCALE AND COST OF BIG PHARMA’S PRICE HIKES THAT EXCEED INFLATION

Rx Price Watch Analysis Finds Big Pharma Price Increases Outpaced Inflation Every Year Except One Between 2006 and 2020 A new report from AARP finds Big Pharma “consistently” increased prices

01-19-2024 Read More

CSRXP: BIG PHARMA’S JANUARY PRICE HIKES CLIMB TO 775 AS PHARMACEUTICAL INDUSTRY DOUBLES DOWN ON BUSINESS-AS-USUAL APPROACH TO PRICE-GOUGING

Brand Name Drug Companies’ Price Increases in First Two Weeks of 2024 Continue to Outpace the Rate of Inflation Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a

01-18-2024 Read More

BIG PHARMA WATCH: BIG PHARMA DELAYS NEW DRUGS THAT COULD HELP PATIENTS TO BOOST PROFITS

Report Finds Several Brand Name Drug Companies Waiting to Introduce New Products Until They Can Get Approval for More Lucrative Disease Classes  It appears egregious price hikes on existing

01-8-2024 Read More

CSRXP: GSK’S FLOVENT SCHEME DESIGNED TO SIDESTEP ACCOUNTABILITY FOR EGREGIOUS PRICE HIKES

Big Pharma Giant Switches Popular Brand Name Inhaler to Authorized Generic to Maintain Monopoly Pricing Power and End-Run Solutions Meant to Discourage Price Increases Above the Rate of Inflation

01-5-2024 Read More

DOSE OF REALITY: BIG PHARMA’S R&D INVESTMENTS DISCREDIT DOOM AND GLOOM INNOVATION RHETORIC

Report Finds Big Pharma Increased Spending on R&D in First Half of 2023, Made R&D Investment Decisions Without Considering Impact of 2022 Drug Pricing Solutions A recent analysis from

01-5-2024 Read More

CSRXP: BIG PHARMA RINGS IN 2024 WITH EGREGIOUS PRICE HIKES ON HUNDREDS OF BRAND NAME PRESCRIPTION DRUGS

Big Pharma Maintains Business-as-Usual Approach to Price-Gouging Americans to Start the New Year Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement today on

01-2-2024 Read More

DOSE OF REALITY: BREAKING DOWN BIG PHARMA’S YEAR OF BAD BEHAVIOR IN 2023: PART V: BIG PHARMA’S DEBUNKED INNOVATION RHETORIC

Big Pharma Discredited Its Own Bogus Rhetoric on Research and Development in 2023 With each new year comes a time-honored tradition for Big Pharma: Hiking prices on hundreds of brand name

01-1-2024 Read More

DOSE OF REALITY: BREAKING DOWN BIG PHARMA’S YEAR OF BAD BEHAVIOR IN 2023: PART IV: TAX AVOIDANCE SCHEMES AND KICKBACKS

Big Pharma’s Tax Avoidance Schemes and Use of Kickbacks to Boost Profits Came Under Fire in 2023 With each new year comes a time-honored tradition for Big Pharma: Hiking prices on hundreds of

12-29-2023 Read More

DOSE OF REALITY: BREAKING DOWN BIG PHARMA’S YEAR OF BAD BEHAVIOR IN 2023: PART III: BIG PHARMA’S ANTI-COMPETITIVE TACTICS

Exploring the Cost of Big Pharma’s Egregious Abuse of the Patent System With each new year comes a time-honored tradition for Big Pharma: Hiking prices on hundreds of brand name prescription drugs

12-28-2023 Read More

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.